Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$83.14 - $145.99 $23.3 Million - $40.9 Million
280,000 New
280,000 $40.8 Million
Q4 2020

Feb 16, 2021

SELL
$65.07 - $98.24 $39 Million - $58.9 Million
-599,091 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$59.04 - $77.95 $22.5 Million - $29.7 Million
-381,370 Reduced 38.9%
599,091 $38.9 Million
Q2 2020

Aug 14, 2020

BUY
$29.01 - $74.23 $28.4 Million - $72.8 Million
980,461 New
980,461 $71.7 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.